Member Info for Skippysb01

B1ll - no worries. I'm being grumpy.

I guess what I wanted to get across to fellow shareholders is that whilst no deal is guaranteed they should not lose heart because of the time it's taking since DD was done. In my experience the lawyers will take as long as it takes and it can be hard yards.

Hop2 - that concerns me too. 2 young kids and no protection for them. I want authorities and everyone else to assume it will be harmful until we can prove it isn't.

B1ll - I didnt suggest you did but it is clear that there is a theme of - if DD is done what could possible be left to do? - and I thought it would be helpful to post something based on my experience....

In any case the legal work is not 'just admin'. It is a hugely material part of this process and takes time. EUA doesn't do Due Diligence on assets it is selling (although they may have done work to verify the credibility of the buyer at the start of the process), the buyer does due diligence and it is of enormous importance - not tyre kicking.

LiveLif - you wrote 'You see what you want to see, hear what you want to hear.'

The WHO says this - 'Severity of disease: It is not yet clear whether infection with Omicron causes more severe disease compared to infections with other variants, including Delta. Preliminary data suggests that there are increasing rates of hospitalization in South Africa, but this may be due to increasing overall numbers of people becoming infected, rather than a result of specific infection with Omicron. There is currently no information to suggest that symptoms associated with Omicron are different from those from other variants. Initial reported infections were among university students—younger individuals who tend to have more mild disease—but understanding the level of severity of the Omicron variant will take days to several weeks. All variants of COVID-19, including the Delta variant that is dominant worldwide, can cause severe disease or death, in particular for the most vulnerable people, and thus prevention is always key. '

You see that we can all select which data to use to support our bias but I have chosen to produce the actual WHO position.
You chose to select data that suggests that the Omicron variant produces less serious symptoms. This was anecdotal. I and other have suggested we need to wait for more data.

You see? The plural of 'anecdote' is not data.

The video last week was publicity. So yes I expect an RNS soon that describes what the status and plan is very soon.

LiveIf. You just sounded quite ridiculous and not very self aware. You have to realise that if data was being presented that supported your views the people on this board would be very open to understanding that. But you have nothing but bias and it just won't work here. Bye.

Due diligence and the legal requirements of completing an acquisition deal are not the same.

Due Diligence - the process of understanding the assets (includes value but far from exclusively so) that would be purchased and validating any assumptions and facts to the satisfaction of the BOD of the buying entity. Granted the lawyers would review this on behalf of the buying entity. EUA most likely will not see this but will have been asked to provide data/documents and access for it's completion.

Legal work. Reviewing effectively everything to ensure it is legally correct & binding and for the buyer and seller that the deal is in the best interests 'legally' of each party - separately. Review of external legal document such as licenses, permissions etc of which there will be many and including asking third parties to address discrepancies etc. Documentation of legal documents pertaining to the deal of which there will be many. Documentation of the final contract. In my experience lawyers disagree on many many points and are required to compromise which takes time to narrow caveats down to acceptable risk for both parties.

Very tough yards. Objectively I would say there 'may' have been time to complete since the DD was done. Therefore from an investment risk perspective we could get an RNS about it at any moment but it could also take longer.

There is absolutely no way that the BOD of either party will rush a deal that is not in the best interests of shareholders and taking longer is an appropriate risk mitigant in these circumstances.

I bet 'The WHO' did not say that. Dr Who maybe but not the World Health Organisation that has been calling for caution throughout.

What I meant to type, if I wasn't being helped by Apple, would have been in English.

It's not currently known whether Omicron causes mild or severe illness. I think assume the worsed case until more data is available would be the smart move.

Re the thread - we can trust that SNG will verify performance v Omicron as soon as they can. There will be many more variants too. We know that SNG has a very very high chance of having efficacy across all variants where interferon response is a key factor.

Its not currently know whether Omicron causes mild or sever illness. Is I think assume the worse case until more data is available would be the smart move.

What? Dragging it out? You mean the development of sensitive and life changing scientific equipment?

I'm not sure you having to wait is the priority.

Them tiny trades. Not just the 1's but anything small. I note they tend to be at a slightly bigger spread so lower bid and higher ask. To me they are trades on zero fee platforms.

There is no such thing as a free lunch - or trade for that matter.

Amagedon21 - Not disagreeing. Just that the September RNS pointed to a separate update that would be just about the bladder cancer and sepsis testing so I would not be surprised to see a separate RNS on that. You may be right that the content in the Interim report might cover it for now.

Manutdbo12 - that was my thinking too. I thought separate meant standalone. Well it's only 1st December so let's see.

I kinda felt that the small update on the bladder cancer and sepsis test in the interim report was not the update promised for November in the RNS from September. Now, reading it again I suppose it could be or at least it's enough to justify not having another RNS on it in November.

I do think there will be an RNS soon on the Covid test that describes the next steps following the video released recently and recent form is they like to update on all of the tests at the same time.

Any time now.

BBaggins. You forget yourself. You are neocantus on this thread.

Do not take me for a conjuror of cheap tricks....

It seems that Bilbo is not the only poster quoting the RNS 'Until a transaction is finally concluded there can be no certainty that a transaction will occur or on what terms.'

Which of course is just a standard clause covering risk that any RNS of this type must include.

I also note similarities in language and writing styles. It's uncanny!!!

There is no way that an RNS of that type could be released without including that standard inclusion covering risk. Everybody invested knows that there is no deal until there is a deal.

You negative interpretation of this clause is rather pointless.

What is this 'dark pool' mystery?

We should get an update on Sepsis and Bladder cancer tests today. It was stated in September RNS that they would update on these in November. Whether we will or not I don’t know but ‘could’ be.